Disappearing or residual tiny (≤5 mm) colorectal liver metastases after chemotherapy on gadoxetic acid-enhanced liver MRI and diffusion-weighted imaging: Is local treatment required?

[1] Jemal A(2011)Global cancer statistics CA Cancer J Clin 61 69-90

[2] Bray F(2006)Epidemiology and management of liver metastases from colorectal cancer Ann Surg 244 254-259

[3] Center MM(1995)Resection of colorectal liver metastases World J Surg 19 59-71

[4] Ferlay J(1994)Liver metastases from colorectal carcinoma: incidence, resectability, and survival results Am Surg 60 929-933

[5] Ward E(2010)Systematic review of randomized and nonrandomized trials of the clinical response and outcomes of neoadjuvant systemic chemotherapy for resectable colorectal liver metastases Ann Surg Oncol 17 492-501

[6] Forman D(2006)Complete response of colorectal liver metastases after chemotherapy: does it mean cure? J Clin Oncol 24 3939-3945

[7] Manfredi S(2015)Incremental value of liver MR imaging in patients with potentially curable colorectal hepatic metastasis detected at CT: a prospective comparison of diffusion-weighted imaging, gadoxetic acid-enhanced MR imaging, and a combination of both MR techniques Radiology 274 712-722

[8] Lepage C(2013)Preoperative evaluation of colorectal liver metastases: comparison between gadoxetic acid-enhanced 3.0-T MRI and contrast-enhanced MDCT with histopathological correlation Eur Radiol 23 2187-2196

[9] Hatem C(2011)Diagnosis of colorectal hepatic metastases: comparison of contrast-enhanced CT, contrast-enhanced US, superparamagnetic iron oxide-enhanced MRI, and gadoxetic acid-enhanced MRI J Magn Reson Imaging 34 326-335

[10] Coatmeur O(2016)Colorectal liver metastases: disappearing lesions in the era of Eovist hepatobiliary magnetic resonance imaging HPB (Oxford) 18 296-303

[1] Jemal A(2011)Global cancer statistics CA Cancer J Clin 61 69-90

[2] Bray F(2006)Epidemiology and management of liver metastases from colorectal cancer Ann Surg 244 254-259

[3] Center MM(1995)Resection of colorectal liver metastases World J Surg 19 59-71

[4] Ferlay J(1994)Liver metastases from colorectal carcinoma: incidence, resectability, and survival results Am Surg 60 929-933

[5] Ward E(2010)Systematic review of randomized and nonrandomized trials of the clinical response and outcomes of neoadjuvant systemic chemotherapy for resectable colorectal liver metastases Ann Surg Oncol 17 492-501

[6] Forman D(2006)Complete response of colorectal liver metastases after chemotherapy: does it mean cure? J Clin Oncol 24 3939-3945

[7] Manfredi S(2015)Incremental value of liver MR imaging in patients with potentially curable colorectal hepatic metastasis detected at CT: a prospective comparison of diffusion-weighted imaging, gadoxetic acid-enhanced MR imaging, and a combination of both MR techniques Radiology 274 712-722

[8] Lepage C(2013)Preoperative evaluation of colorectal liver metastases: comparison between gadoxetic acid-enhanced 3.0-T MRI and contrast-enhanced MDCT with histopathological correlation Eur Radiol 23 2187-2196

[9] Hatem C(2011)Diagnosis of colorectal hepatic metastases: comparison of contrast-enhanced CT, contrast-enhanced US, superparamagnetic iron oxide-enhanced MRI, and gadoxetic acid-enhanced MRI J Magn Reson Imaging 34 326-335

[10] Coatmeur O(2016)Colorectal liver metastases: disappearing lesions in the era of Eovist hepatobiliary magnetic resonance imaging HPB (Oxford) 18 296-303